Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has subscribed to a third structured deposit with BoCD for RMB200 million, bringing the total structured deposits to RMB450 million. The latest deposit, part of a series of investments with BoCD, offers a principal-guaranteed with a floating return and is linked to the EUR/USD exchange rate. This transaction is classified as discloseable under the Listing Rules, necessitating public disclosure due to its financial significance.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.